Sight Sciences, Inc. (SGHT) Guidance & Earnings Results
On 2026-08-05 Sight Sciences, Inc. raised guidance: "FY2026 revenue guidance raised to $88M-$92M (14-19%…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SGHTSight Sciences, Inc.Follow SGHT — free
—
Price chart with a free account
- Market cap
- 495.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 10 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 5 Aug 26 | Raised | FY2026 revenue guidance raised to $88M-$92M (14-19% growth) · full year |
| 6 May 26 | Raised | FY2026 revenue raised to $83-89M from $82-88M; Interventional Glaucoma $77-81M; Interventional Dry Eye $6-8M; adjusted operating expenses reaffirmed at $93-96M · full year |
| 4 Mar 26 | Raised | FY2026 revenue $82-88M (6-14% growth); Interventional Glaucoma $77-81M (2-7% growth); Interventional Dry Eye $5-7M (vs $1.6M in 2025) · full year |
| 6 Nov 25 | Raised | FY2025 revenue guidance raised to $90-92M (from prior undisclosed); FY2025 adjusted operating expenses guidance reduced to $90-92M from $95-99M; workforce reduction savings ~$12M annualized · full year |
| 7 Aug 25 | Raised | FY2025 revenue raised to $72-76M from $70-75M; FY2025 adjusted operating expenses reaffirmed at $101-105M · full year |
Sight Sciences, Inc. — questions
- What guidance did Sight Sciences, Inc. give?
- On 2026-08-05: "FY2026 revenue guidance raised to $88M-$92M (14-19% growth)"
- When does Sight Sciences, Inc. report earnings?
- Sight Sciences, Inc.'s next earnings report is expected on 2026-11-04.
Every figure on this page comes from Sight Sciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.